glp-1 pathophysiology 𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿 𝗔𝗴𝗼𝗻𝗶𝘀𝘁𝘀 𝗼𝗻 𝗚𝗹𝘆𝗰𝗮𝘁𝗲𝗱 𝗛𝗲𝗺𝗼𝗴𝗹𝗼𝗯𝗶𝗻 𝗟𝗲𝘃𝗲𝗹𝘀 ⁣ ⁣ Randomized, placebo-controlled trials of the glucagon-like peptide-1 (GLP-1) receptor agonists have provided strong Frontiers | GLP-1 Receptor Agonists:

These trends are expected to have a material impact on a number of non-health industries, with some benefiting and others disadvantaged, although there is a lack of consensus on the scale and timing of the impact

however, this example, combined with the others above, also highlights that activation or inhibition of these enzymes is beneficial in a context-dependent manner

6 * Moderate risk defined as people with CVD

Lemontt JF, Generoso WM (eds)

Dulaglutide, a longacting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes

Research on GLP-1 use in post-cholecystectomy cohorts is limited but growing